Welcome to the HBOT News Network
Hyperbaric Oxygen Therapy (HBOT) is increasingly appearing in the news and new research as a treatment for a variety of conditions involving inflammation. Use the search or select an article below to keep up to date on the most recent HBOT News.
Recent Hyperbaric Oxygen Therapy (HBOT) News
Hyperbaric oxygen therapy in the treatment of COVID-19 — severe cases
From Wuhan China — promising results have just been published by Dr. Zhong Yangling for the treatment of 5 COVID-19 patients (2 of which were critical and 3 were severe) with hyperbaric therapy at the Department of Hyperbaric Oxygen in Wuhan...
Hyperbaric Oxygen Therapy for New Coronavirus Pneumonia
From the pathophysiological characteristics of new coronavirus pneumonia (NCP) and the effect mechanism analysis of hyperbaric oxygen therapy (HBOT), HBOT may have a good effect in the treatment of NCP persistent hypoxemia. In view of the NCP...
Potential of HBOT Treatment for Coronavirus is Supported by New Evidence
In the last 24 hours, two new pieces of evidence have surfaced supporting Dr Harch’s original proposal of 3/3/2020 to consider HBOT for the treatment of coronavirus infection. (Update 3/17/2020)Today, the publication of a retrospective analysis of...
Orange County Coronavirus Patient Flown From Aruba To LAX: Report
A 65-year-old coronavirus patient was inside a pressured isolation chamber, and transported to an Orange County hospital, reports say.ORANGE COUNTY, CA — A man believed to have contracted coronavirus while overseas was flown to Los Angeles on a...
Coronavirus & Hyperbaric Oxygen Therapy
Hyperbaric Medicine International recently published a White Paper on the use of Hyperbaric Oxygen Therapy (HBOT) for the treatment of patients with COVID-19 as well as At-Risk population to prevent or reduce the effects of COVID-19. According to...
Hyperbaric Application to COVID-19 Pulmonary Infection
In the midst of the corona virus epidemic/pandemic it bears remembering the application of hyperbaric oxygen therapy to the last major pandemic that impacted the United States in 1918, the Spanish Flu Pandemic. Death was primarily by pulmonary...
Legally blind Northstate woman regains her vision through oxygen therapy
When artist, Darcy Wilson's right eye suffered from 1/3 vision loss after a stroke, her Ophthalmologist urgently sent her over to the Mercy Medical Center's Wound, Healing and Hyperbaric Center to immediately start hyperbaric oxygen therapy (HBOT)....
Study Shows Hyperbaric Oxygen Therapy (HBOT) Protocols Can Improve Cognitive Function in Stroke Patients
One of the largest hyperbaric chamber centers in the world, The Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center, announced study results which indicate that HBOT (hyperbaric oxygen therapy) produced significant...
Hyperbaric Oxygen Therapy gets Lincoln CPA back in business for tax season
17 years ago Tom Shotkoski was diagnosed with colorectal cancer. But, when his surgical site became infected, Shotsoski was left with a life of debilitating pain that restricted him from even being able to sit. His doctors recommended Hyperbaric...
Recent Hyperbaric Oxygen Therapy (HBOT) Research
Hyperbaric oxygen therapy for mild traumatic brain injury persistent postconcussion syndrome: a randomized controlled trial
Abstract: Persistent postconcussion syndrome (PPCS) after mild traumatic brain injury (mTBI) is a significant public health and military problem for which there is limited treatment evidence. The aim of this study was to determine whether forty 150...
Hyperbaric oxygen therapy improves neurocognitive functions of post-stroke patients – a retrospective analysis.
Abstract: BackgroundPrevious studies have shown that hyperbaric oxygen therapy (HBOT) can improve the motor functions and memory of post-stroke patients in the chronic stage. ObjectiveThe aim of this study is to evaluate the effects of HBOT...
Fitness genes of group A streptococci in necrotizing fasciitis and myositis.
Abstract: Necrotizing fasciitis and myositis caused by group A streptococci (GAS) are among the most fulminating infections, with a mortality rate of 20% to 30%. Although numerous regimens have been utilized in attempts to control these devastating...
The effect of hyperbaric oxygenation therapy on myocardial function
Abstract: Hyperbaric oxygenation therapy is successfully implemented for the treatment of several disorders. Data on the effect of hyperbaric oxygenation on echocardiographic parameters in asymptomatic patients is limited. The current study sought...
Local doctor continues to push VA to approve Hyperbaric Oxygen Therapy for veterans
The AC133 antigen is a novel antigen selectively expressed on a subset of CD34+ cells in human fetal liver, bone marrow, and blood as demonstrated by flow cytometric analyses. In this study, we have further assessed the expression of AC133 on CD34+ cells in hemopoietic samples and found that there was a highly significant difference between normal bone marrow and cord blood versus aphereses (p <0.0001) but not between bone marrow and cord blood. Most of the clonogenic cells (67%) were contained in the CD34+AC133+ fraction. Compared with cultures of the CD34+AC133- cells, generation of progenitor cells in long-term culture on bone marrow stroma was consistently 10- to 100-fold higher in cultures initiated with CD34+AC133+ cells and was maintained for the 8-10 weeks of culture.
Is There an Association Between Hyperbaric Oxygen Therapy and Improved Outcome of Deep Chemical Peeling? A Randomized Pilot Clinical Study.
Abstract: Phenol chemical peeling (PCP) treatment is associated with prolonged recovery and sustained adverse events. Hyperbaric oxygen therapy (HBOT) is known to accelerate wound healing. The purpose of the current study was to evaluate the effect...
Retrospective Case Series of Traumatic Brain Injury and Post-Traumatic Stress Disorder Treated with Hyperbaric Oxygen Therapy
Returning veterans are frequently diagnosed with traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD). Considering a recent case-controlled study of hyperbaric oxygen therapy (HBOT) reporting a reduction in suicidal ideation, we investigated retrospectively three veterans with chronic TBI/PTSD symptoms who were treated with multiple rounds of HBOT with neurophysiological testing performed before and after treatment. Improvements were detected on parameters within neurocognitive domains, including reductions in suicide-related symptoms. These findings independently confirm that HBOT may be effective in treating specific symptoms of TBI/PTSD that are not currently addressed with existing therapeutic approaches.
Treatment of Traumatic Brain Injury With Hyperbaric Oxygen Therapy
Hyperbaric oxygen therapy (HBOT) is defined as the use of oxygen at higher than atmospheric pressure for the treatment of underlying disease processes and the diseases they produce. Modern HBOT in which 100% O2 is breathed in a pressurized chamber dates back to the 1930s, when it was first used for treatment of decompression illness in divers. There are currently 13 FDA-approved uses for HBOT, including decompression illness, gas gangrene, air embolism, osteomyelitis, radiation necrosis, and the most recent addition—diabetic ulcers. HBOT can dramatically and permanently improve symptoms of chronic TBI months or even many years after the original head injury. This assertion is generally met with skepticism within the medical establishment because we have been taught for generations that any post-concussion symptoms persisting more than 6 months or so after a head injury are due to permanent brain damage that cannot be repaired.
The National Brain Injury Rescue and Rehabilitation Study – a multicenter observational study of hyperbaric oxygen for mild traumatic brain injury with post-concussive symptoms
The National Brain Injury Rescue and Rehabilitation Project was established as a preliminary study to test the safety and practicality of multi-center hyperbaric oxygen administration for the post-concussive symptoms of chronic mild traumatic brain injury as a precursor to a pivotal, independent, multi-center, controlled clinical trial. This report presents the results for 32 subjects who completed a preliminary trial of hyperbaric oxygen several years before the passage of the 21 st Century Cures Act. This study anticipated the Act and its reassessment of clinical research. Subjects received 40-82 one-hour treatments at 1.5 atmospheres absolute 100% oxygen. Outcome measures included repeated self-assessment measures and automated neurocognitive tests. The subjects demonstrated improvement in 21 of 25 neurocognitive test measures observed. The objective neurocognitive test components showed improvement in 13 of 17 measures. Earlier administration of hyperbaric oxygen post injury, younger age at the time of injury and hyperbaric oxygen administration, military status, and increased number of hyperbaric oxygen administrations were characteristics associated with improved outcomes. There were no adverse events. Hyperbaric oxygen was found to be safe, inexpensive and worthy of clinical application in the 21 st Century model of facile data collection provided by recent research regulatory shifts in medicine. The study was approved by the ethics review committee of the Western Institutional Review Board (WIRB; Protocol #20090761).